163 related articles for article (PubMed ID: 21689086)
1. Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.
Roy NB; Myerson S; Schuh AH; Bignell P; Patel R; Wainscoat JS; McGowan S; Marchi E; Atoyebi W; Littlewood T; Chacko J; Vyas P; Killick SB
Br J Haematol; 2011 Aug; 154(4):521-4. PubMed ID: 21689086
[TBL] [Abstract][Full Text] [Related]
2. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study.
Mantovani LF; Santos FPS; Perini GF; Nascimento CMB; Silva LP; Wroclawski CK; Esposito BP; Ribeiro MSS; Velloso EDRP; Nomura CH; Kay FU; Baroni RH; Hamerschlak N; Schuster S
Leuk Res; 2019 Jan; 76():53-57. PubMed ID: 30572266
[TBL] [Abstract][Full Text] [Related]
4. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
5. Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.
Du Y; Long Z; Chen M; Han B; Hou B; Feng F
Acta Haematol; 2017; 138(2):119-128. PubMed ID: 28866669
[TBL] [Abstract][Full Text] [Related]
6. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.
Bowen DT; Hellström-Lindberg E; Steensma DP
Br J Haematol; 2014 Feb; 164(4):610-1. PubMed ID: 24236802
[No Abstract] [Full Text] [Related]
7. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique.
Konen E; Ghoti H; Goitein O; Winder A; Kushnir T; Eshet Y; Rachmilewitz E
Am J Hematol; 2007 Nov; 82(11):1013-6. PubMed ID: 17654681
[TBL] [Abstract][Full Text] [Related]
8. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients.
Pascal L; Beyne-Rauzy O; Brechignac S; Marechaux S; Vassilieff D; Ernst O; Berthon C; Gyan E; Gourin MP; Dreyfus F; Fenaux P; Rose C
Br J Haematol; 2013 Aug; 162(3):413-5. PubMed ID: 23656172
[No Abstract] [Full Text] [Related]
9. Deferasirox in MDS patients with transfusion-caused iron overload--a phase-II study.
Metzgeroth G; Dinter D; Schultheis B; Dorn-Beineke A; Lutz K; Leismann O; Hehlmann R; Hastka J
Ann Hematol; 2009 Apr; 88(4):301-10. PubMed ID: 18758781
[TBL] [Abstract][Full Text] [Related]
10. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients, the GFM experience: response to Bowen et al.
Rose C; Pascal L; Fenaux P
Br J Haematol; 2014 Feb; 164(4):612-3. PubMed ID: 24206064
[No Abstract] [Full Text] [Related]
11. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
Malcovati L
Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
[TBL] [Abstract][Full Text] [Related]
12. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.
Greenberg PL; Koller CA; Cabantchik ZI; Warsi G; Glynos T; Paley C; Schiffer C
Leuk Res; 2010 Dec; 34(12):1560-5. PubMed ID: 20615548
[TBL] [Abstract][Full Text] [Related]
14. [The role of iron metabolism in myelodysplastic syndromes].
Finelli C; Clissa C; Stanzani M
Recenti Prog Med; 2014 Mar; 105(3):123-6. PubMed ID: 24675455
[TBL] [Abstract][Full Text] [Related]
15. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.
de Montalembert M; Ribeil JA; Brousse V; Guerci-Bresler A; Stamatoullas A; Vannier JP; Dumesnil C; Lahary A; Touati M; Bouabdallah K; Cavazzana M; Chauzit E; Baptiste A; Lefebvre T; Puy H; Elie C; Karim Z; Ernst O; Rose C
PLoS One; 2017; 12(3):e0172147. PubMed ID: 28257476
[TBL] [Abstract][Full Text] [Related]
16. Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China.
Wang Y; Huang L; Hua Y; Liu H; Jiang H; Wang H; Zhang W; Fu R; Shao Z
Hematology; 2021 Dec; 26(1):874-880. PubMed ID: 34753406
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
Wahidiyat PA; Iskandar SD; Sekarsari D
Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
[TBL] [Abstract][Full Text] [Related]
18. Delineating parameters of iron overload in MDS patients treated with deferasirox.
Leitch HA
Leuk Res; 2010 Dec; 34(12):1556-7. PubMed ID: 20719382
[No Abstract] [Full Text] [Related]
19. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
20. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia.
Unal S; Cetin M; Hazirolan T; Yildirim G; Meral A; Birbilen A; Karabulut E; Aytac S; Tavil B; Kuskonmaz B; Tuncer M; Gumruk F
Leuk Res; 2014 Aug; 38(8):882-5. PubMed ID: 24933623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
